N. Markowitz

发表

Monoclonal Antibody against TNF: A Non-Antibiotic Strategy for the Treatment of Sepsis

R. Pokriefka, L. Saravolatz, N. Markowitz, 1993 .

CD4+ count-guided interruption of antiretroviral treatment.

J Darbyshire, N Clumeck, J Hoy, 2006, The New England journal of medicine.

Imipenem-cilastatin in the treatment of methicillin-sensitive and methicillin-resistant Staphylococcus aureus infections

L. Saravolatz, N. Markowitz, R. del Busto, 1986, Antimicrobial Agents and Chemotherapy.

Effect of IL‐2 on hepatitis C virus RNA levels in patients co‐infected with human immunodeficiency virus receiving HAART

N. Markowitz, E. Tedaldi, L. Chen, 2005, Journal of viral hepatitis.

In vitro susceptibility patterns of methicillin-resistant and-susceptible Staphylococcus auerues strains in a population of parenteral drug abusers from 1972 to 1981

L. Saravolatz, N. Markowitz, D. Pohlod, 1983, Antimicrobial Agents and Chemotherapy.

Routine analysis of induced sputum is not an effective strategy for screening persons infected with human immunodeficiency virus for Mycobacterium tuberculosis or Pneumocystis carinii. Pulmonary Complications of HIV Infection Study Group.

P. Kvale, N. Hansen, N. Markowitz, 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

INSIGHT FLU005: An Anti-Influenza Virus Hyperimmune Intravenous Immunoglobulin Pilot Study.

R. Dewar, J. Metcalf, R. Davey, 2016, The Journal of infectious diseases.

Cancer Incidence among an HIV-infected Cohort

P. Kvale, P. Hopewell, N. Markowitz, 1997 .

Gender is not a factor in serum human immunodeficiency virus type 1 RNA levels in patients with viremia

P. Kvale, L. Saravolatz, N. Markowitz, 1996, Journal of clinical microbiology.

Relative efficacy and toxicity of netilmicin and tobramycin in oncology patients.

L. Saravolatz, N. Markowitz, G. Gorse, 1986, Archives of internal medicine.

Evolocumab in HIV-Infected Patients With Dyslipidemia

Paul D. Thompson, S. Trottier, C. Fichtenbaum, 2020, Journal of the American College of Cardiology.

Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial

Rebecca M. Baker, Phuong Thi Tuyet Nguyen, Carol L. Eyler, 2021, The Lancet Infectious Diseases.

Neurological manifestations of acquired immunodeficiency syndrome.

N. Markowitz, M. Rosenblum, 2007, Journal of neurosurgery.

A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19

Samuel M. Brown, Christina C. Chang, W. Self, 2020, The New England journal of medicine.

A study of HIV RNA viral load in AIDS patients with bacterial pneumonia.

P. Kvale, L. Saravolatz, N. Markowitz, 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

HCV Enters the Twenty-First Century

N. Markowitz, D. Baxa, I. Brar, 2013, Current Infectious Disease Reports.

Descriptive Analysis of Patients Living With HIV Affected by COVID-19

N. Markowitz, N. Yared, I. Brar, 2020, Journal of acquired immune deficiency syndromes.

Anti-Influenza Hyperimmune Immunoglobulin Enhances Fc-Functional Antibody Immunity During Human Influenza Infection

R. Davey, H. Lane, S. Kent, 2018, The Journal of infectious diseases.

Increased Indoleamine-2,3-Dioxygenase Activity Is Associated With Poor Clinical Outcome in Adults Hospitalized With Influenza in the INSIGHT FLU003Plus Study

T. Griffin, R. Dewar, J. Metcalf, 2017, Open forum infectious diseases.

Patterns of HIV-1 and HTLV-I/II in intravenous drug abusers from the middle atlantic and central regions of the USA.

W. Blattner, Helen H. Lee, S. Weiss, 1990, The Journal of infectious diseases.

Bacterial pneumonia in persons infected with the human immunodeficiency virus. Pulmonary Complications of HIV Infection Study Group.

R. Hirschtick, P. Kvale, P. Hopewell, 1995, The New England journal of medicine.

Comparison of the Outcomes of Individuals With Medically Attended Influenza A and B Virus Infections Enrolled in 2 International Cohort Studies Over a 6-Year Period: 2009–2015

R. Schooley, E. Maltezos, Tak-chiu Wu, 2017, Open forum infectious diseases.

Adult Neurological Complications Associated with Seasonal Influenza Infection

N. Markowitz, L. Johnson, M. Usman, 2015 .

Rapid decrease in unintegrated human immunodeficiency virus DNA after the initiation of nucleoside therapy.

L. Saravolatz, N. Markowitz, R. Donovan, 1994, The Journal of infectious diseases.

The emerging role of HTLV-I/II and HIV-1 among intravenous drug users in Detroit.

L. Saravolatz, N. Markowitz, C. Lewandowski, 1992, Henry Ford Hospital medical journal.

Long term effects of intermittent IL 2 in HIV infection : extended follow

D. Wentworth, N. Markowitz, A. Babiker, 2019 .

The role of tumor necrosis factor in sepsis.

L. Saravolatz, N. Markowitz, C. Spooner, 1992, Clinical immunology and immunopathology.

Trimethoprim-Sulfamethoxazole Compared with Vancomycin for the Treatment of Staphylococcus aureus Infection

L. Saravolatz, N. Markowitz, E. Quinn, 1992, Annals of Internal Medicine.

Cryptococcal empyema: case report and review.

N. Markowitz, W. Dismukes, V. Mulanovich, 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The urological manifestations of the acquired immunodeficiency syndrome.

B. Miles, N. Markowitz, E. Fisher, 1989, The Journal of urology.

Methicillin-resistant Staphylococcus aureus. Epidemiologic observations during a community-acquired outbreak.

L. Saravolatz, N. Markowitz, D. Pohlod, 1982, Annals of internal medicine.

Human infection with Ehrlichia canis, a leukocytic rickettsia

N. Markowitz, J. Mcdade, M. Ristic, 1987 .

Antibiotic susceptibility patterns in an ICU at a tertiary hospital in New Delhi, India.

N. Markowitz, V. Myneedu, M. Zervos, 2015, Journal of global antimicrobial resistance.

Zidovudine alone or in combination with didanosine or zalcitabine in HIV-infected patients with the acquired immunodeficiency syndrome or fewer than 200 CD4 cells per cubic millimeter. Investigators for the Terry Beirn Community Programs for Clinical Research on AIDS.

C. Pettinelli, J. Hodges, M. Loveless, 1996, The New England journal of medicine.

Tuberculin and Anergy Testing in HIV-Seropositive and HIV-Seronegative Persons

P. Kvale, P. Hopewell, B. Mangura, 1993, Annals of Internal Medicine.

A decline in the pulmonary diffusing capacity does not indicate opportunistic lung disease in asymptomatic persons infected with the human immunodeficiency virus. Pulmonary Complications of HIV Infection Study Group.

P. Kvale, P. Hopewell, N. Hansen, 1993, The American review of respiratory disease.

Safety, pharmacokinetics, and functional activity of human anti-Pseudomonas aeruginosa monoclonal antibodies in septic and nonseptic patients.

L. Saravolatz, N. Markowitz, J. Pennington, 1991, The Journal of infectious diseases.

Human infection with Ehrlichia canis, a leukocytic rickettsia.

N. Markowitz, J. Mcdade, M. Ristic, 1987, The New England journal of medicine.

Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels

Samuel M. Brown, Christina C. Chang, W. Self, 2021, Annals of Internal Medicine.

Evaluation of a Rapid Syphilis Test in an Emergency Department Setting in Detroit, Michigan.

P. Peters, N. Markowitz, K. Hoover, 2019, Sexually transmitted diseases.

Infected false aneurysms of the femoral artery in intravenous drug addicts.

L. Saravolatz, N. Markowitz, D. Reddy, 1989, Reviews of infectious diseases.

Changes in virus load markers during AIDS-associated opportunistic diseases in human immunodeficiency virus-infected persons.

L. Saravolatz, N. Markowitz, R. Donovan, 1996, The Journal of infectious diseases.

Randomized, Open‐Label Study of the Impact of Two Doses of Subcutaneous Recombinant Interleukin‐2 on Viral Burden in Patients With HIV‐1 Infection and CD4+ Cell Counts of ≥300/mm3: CPCRA 059

R. Davey, N. Markowitz, E. Denning, 2002, Journal of acquired immune deficiency syndromes.

Increased detection of human immunodeficiency virus antigenemia after dissociation of immune complexes at low pH

P. Kvale, R. Pokriefka, L. Saravolatz, 1993, Journal of clinical microbiology.

Infection surveillance in cardiac transplantation.

L. Saravolatz, N. Markowitz, D. Magilligan, 1988, American journal of infection control.

Changes in plasma HIV RNA levels and CD4 cell counts after vaccination of pediatric patients

L. Saravolatz, N. Markowitz, R. Donovan, 1997, AIDS.

Pentamidine aerosol versus trimethoprim-sulfamethoxazole for Pneumocystis carinii in acquired immune deficiency syndrome.

N. Markowitz, D. Feigal, A. Catanzaro, 1995, American journal of respiratory and critical care medicine.

CD4 is expressed on a heterogeneous subset of hematopoietic progenitors, which persistently harbor CXCR4 and CCR5-tropic HIV proviral genomes in vivo

S. Morrison, N. Markowitz, K. Collins, 2017, PLoS pathogens.

Long-Term Effects of Intermittent IL-2 in HIV Infection: Extended Follow-Up of the INSIGHT STALWART Study

Abdel Babiker, Norman Markowitz, D. Wentworth, 2012, PloS one.

Nadir CD4+ T cell count predicts response to subcutaneous recombinant interleukin-2.

N. Markowitz, D. Abrams, J. Bebchuk, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A randomized controlled trial evaluating the efficacy and safety of intermittent 3-, 4-, and 5-day cycles of intravenous recombinant human interleukin-2 combined with antiretroviral therapy (ART) versus ART alone in HIV-seropositive patients with 100-300 CD4+ T cells.

H. Lane, S. Koletar, C. Yoshizawa, 2003, Clinical immunology.

The seroprevalence of COVID-19 in patients living with HIV in metropolitan Detroit

N. Markowitz, N. Yared, Sean Yaphe, 2022, International journal of STD & AIDS.

Clinical Prediction Rule for Respiratory Isolation of Patients With Suspected Pulmonary Tuberculosis

James J. Yang, N. Markowitz, I. Brar, 2009 .

Self-report of domestic violence and forced sex are related to sexual risk behaviors in a sample of juvenile detainees

L. Kaljee, N. Markowitz, C. Joseph, 2020, Health & justice.

Incidence of Tuberculosis in the United States among HIV-Infected Persons

P. Kvale, P. Hopewell, B. Mangura, 1997, Annals of Internal Medicine.

Lack of bacterial aerosols associated with heat and moisture exchangers.

L. Saravolatz, N. Markowitz, J. Popovich, 1986, The American review of respiratory disease.

Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial

R. Schooley, R. Dewar, J. Metcalf, 2019, The Lancet. Respiratory medicine.

Occurrence of the S230R integrase strand inhibitor mutation in a treatment-naïve individual case report

N. Markowitz, I. Brar, A. Golembieski, 2020, Medicine.

Patient characteristics and costs associated with dyslipidaemia and related conditions in HIV‐infected patients: a retrospective cohort study

U. Iloeje, M. Pladevall, J. Lafata, 2005, HIV medicine.

NMO-IgG positive relapsing longitudinally extensive transverse myelitis (LETM) in a seropositive HIV patient

N. Markowitz, R. Salazar, M. Cerghet, 2013, Clinical Neurology and Neurosurgery.

Late presentation and transmitted drug resistance mutations in new HIV-1 diagnoses in Detroit.

N. Markowitz, M. Huaman, D. Baxa, 2011, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Early Antiretroviral Therapy at High CD4 Counts Does Not Improve Arterial Elasticity: A Substudy of the Strategic Timing of AntiRetroviral Treatment (START) Trial

H. Jessen, D. Duprez, K. H. Hullsiek, 2016, Open forum infectious diseases.

Quantitation of unintegrated HIV-1 DNA in asymptomatic patients in the presence or absence of antiretroviral therapy.

L. Saravolatz, N. Markowitz, R. Donovan, 1993, AIDS research and human retroviruses.

Hematopoietic Stem and Progenitor Cells Are a Distinct HIV Reservoir that Contributes to Persistent Viremia in Suppressed Patients.

N. Markowitz, K. Collins, D. Bixby, 2018, Cell reports.

Use of trimethoprim-sulfamethoxazole in a glucose-6-phosphate dehydrogenase-deficient population.

L. Saravolatz, N. Markowitz, 1987, Reviews of infectious diseases.

Clinical safety, tolerability, and pharmacokinetics of murine monoclonal antibody to human tumor necrosis factor-alpha.

D. Remick, L. Saravolatz, N. Markowitz, 1994, The Journal of infectious diseases.

Evolocumab Use in HIV-Infected Patients With Dyslipidemia: Primary Results of the Randomized, Double-blind BEIJERINCK Study.

S. Trottier, C. Fichtenbaum, C. Katlama, 2020, Journal of the American College of Cardiology.

Nadir CD 4 + T Cell Count Predicts Response to Subcutaneous Recombinant Interleukin-2

N. Markowitz, D. Abrams, J. Bebchuk, 2003 .

A comparative trial of didanosine or zalcitabine after treatment with zidovudine in patients with human immunodeficiency virus infection. The Terry Beirn Community Programs for Clinical Research on AIDS.

J. Neaton, N. Markowitz, R. Luskin-Hawk, 1994, The New England journal of medicine.

Pulmonary function tests in HIV-infected patients without AIDS. Pulmonary Complications of HIV Infection Study Group.

J. Ware, W. Poole, D. Snider, 1995, American journal of respiratory and critical care medicine.

Simultaneous Runs of the Bayer VERSANT HIV-1 Version 3.0 and HCV bDNA Version 3.0 Quantitative Assays on the System 340 Platform Provide Reliable Quantitation and Improved Work Flow

T. Elbeik, N. Markowitz, V. Ng, 2004, Journal of Clinical Microbiology.

A Randomized Double-Blind Phase 2 Study of Combination Antivirals for the Treatment of Influenza

M. Hughes, R. Schooley, R. Davey, 2017, The Lancet. Infectious diseases.

INSIGHT FLU005: An Anti-Influenza Virus Hyperimmune Intravenous Immunoglobulin Pilot Study.

R. Dewar, J. Metcalf, R. Davey, 2016, The Journal of infectious diseases.